These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27208016)

  • 21. Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily intravenous busulfan-fludarabine-etoposide regimen in pediatric and infant acute lymphoblastic leukemia patients.
    Lee JW; Kang HJ; Kim S; Lee SH; Yu KS; Kim NH; Jang MK; Kim H; Song SH; Park JD; Park KD; Shin HY; Jang IJ; Ahn HS
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):190-5. PubMed ID: 25255163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted-dose of busulfan: Higher risk of sinusoidal obstructive syndrome observed with systemic exposure dose above 5000 µMol⸱min. A historically controlled clinical trial.
    Esteves I; Santos FPS; Ribeiro AAF; Seber A; Sugawara EK; Sobrinho JJDN; Barros JC; Oliveira JSR; Fernandes JF; Hamerschlak N; Andersson BS; de Lima M; Kerbauy FR
    Hematol Oncol; 2020 Dec; 38(5):773-781. PubMed ID: 32779746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
    Yang Y; Zheng F; Xu X; Wang X
    CNS Drugs; 2016 Aug; 30(8):677-88. PubMed ID: 27395404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levetiracetam is associated with improved cognitive outcome for patients with intracranial hemorrhage.
    Taylor S; Heinrichs RJ; Janzen JM; Ehtisham A
    Neurocrit Care; 2011 Aug; 15(1):80-4. PubMed ID: 20890680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?
    Ji YS; Lee MS; Min CW; Park SK; Kim SH; Yun J; Kim HJ; Kim KH; Kim CK; Lee KT; Won JH; Hong DS
    Korean J Intern Med; 2016 Jul; 31(4):750-61. PubMed ID: 27017944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of delayed seizures, delayed cerebral ischemia and poor outcome with the use of levetiracetam versus phenytoin after aneurysmal subarachnoid hemorrhage.
    Karamchandani RR; Fletcher JJ; Pandey AS; Rajajee V
    J Clin Neurosci; 2014 Sep; 21(9):1507-13. PubMed ID: 24919470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimen.
    Satwani P; Bhatia M; Garvin JH; George D; Dela Cruz F; Le Gall J; Jin Z; Schwartz J; Duffy D; van de Ven C; Foley S; Hawks R; Morris E; Baxter-Lowe LA; Cairo MS
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):324-9. PubMed ID: 22079471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis.
    Cotton BA; Kao LS; Kozar R; Holcomb JB
    J Trauma; 2011 Aug; 71(2):375-9. PubMed ID: 21825941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased Systemic Busulfan Exposure After Oral Dosing With Concomitant Levetiracetam Compared With Phenytoin.
    Artul T; Henig I; Nassar L; Yehudai-Ofir D; Scherb I; Lurie Y; Efrati E; Zuckerman T; Kurnik D
    Ther Drug Monit; 2022 Jun; 44(3):414-418. PubMed ID: 34739424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seizures in patients with glioma treated with phenytoin and levetiracetam.
    Merrell RT; Anderson SK; Meyer FB; Lachance DH
    J Neurosurg; 2010 Dec; 113(6):1176-81. PubMed ID: 20560728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term comparison of GOS-E scores in patients treated with phenytoin or levetiracetam for posttraumatic seizure prophylaxis after traumatic brain injury.
    Gabriel WM; Rowe AS
    Ann Pharmacother; 2014 Nov; 48(11):1440-4. PubMed ID: 25169249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safe administration of oral BU twice daily during conditioning for stem cell transplantation in a paediatric population: a comparative study between the standard 4-dose and a 2-dose regimen.
    Mellgren K; Nilsson C; Fasth A; Abrahamsson J; Winiarski J; Ringdén O; Hassan M
    Bone Marrow Transplant; 2008 Apr; 41(7):621-5. PubMed ID: 18084338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenytoin or levetiracetam for seizure prophylaxis in TBI.
    DeDea L
    JAAPA; 2012 Dec; 25(12):11. PubMed ID: 23599996
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison Of Efficacy Of Phenytoin And Levetiracetam For Prevention Of Early Post Traumatic Seizures.
    Khan SA; Bhatti SN; Khan AA; Khan Afridi EA; Muhammad G; Gul N; Zadran KK; Alam S; Aurangzeb A
    J Ayub Med Coll Abbottabad; 2016; 28(3):455-460. PubMed ID: 28712212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
    Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ
    Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Early Posttraumatic Seizures in Children With Moderate to Severe Traumatic Brain Injury Despite Levetiracetam Prophylaxis.
    Chung MG; O'Brien NF
    Pediatr Crit Care Med; 2016 Feb; 17(2):150-6. PubMed ID: 26669640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
    Köle MT; Sager SG; Zeynel H; Çağ Y; Akın Y
    Childs Nerv Syst; 2022 Jul; 38(7):1357-1364. PubMed ID: 35501510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should Levetiracetam or Phenytoin Be Used for Posttraumatic Seizure Prophylaxis? A Systematic Review of the Literature and Meta-analysis.
    Khan NR; VanLandingham MA; Fierst TM; Hymel C; Hoes K; Evans LT; Mayer R; Barker F; Klimo P
    Neurosurgery; 2016 Dec; 79(6):775-782. PubMed ID: 27749510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Once-daily intravenous busulfan with therapeutic drug monitoring compared to conventional oral busulfan improves survival and engraftment in children undergoing allogeneic stem cell transplantation.
    Bartelink IH; Bredius RG; Ververs TT; Raphael MF; van Kesteren C; Bierings M; Rademaker CM; den Hartigh J; Uiterwaal CS; Zwaveling J; Boelens JJ
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):88-98. PubMed ID: 18158965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, efficacy, and pharmacokinetics of intravenous busulfan in children undergoing allogeneic hematopoietic stem cell transplantation.
    Wall DA; Chan KW; Nieder ML; Hayashi RJ; Yeager AM; Kadota R; Przepiorka D; Mezzi K; Kletzel M;
    Pediatr Blood Cancer; 2010 Feb; 54(2):291-8. PubMed ID: 19743300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.